Patients were frail and had a high prevalence of serious comorbidities.
Insulin treatment was the most important cause of severe hypoglycemia.
Among oral drugs, glibenclamide and repaglinide were the main used.
The rate of all-cause mortality was similar with that reported in other studies.
Liver and kidney diseases were the main predictors of hospitalization.